Showing results (271-280 of 351) with videos related to

Sort By:
Pageof 36
Lancet (London, England)|November 9, 2010
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialDick de Zeeuw, Rajiv Agarwal, Michael Amdahl, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 26, 2012
Vitamin D and cancer mortality: systematic review of prospective epidemiological studiesStefan Pilz, Katharina Kienreich, Andreas Tomaschitz, et al.
Clinical Kidney Journal|August 4, 2021
Assessment of kidney function: clinical indications for measured GFRNatalie Ebert, Sebastjan Bevc, Arend Bökenkamp, et al.
Kidney International Reports|January 16, 2026
Heterogeneity of Estimated GFR Slopes According to Etiology, Estimated GFR and Urinary Albumin-to-Creatinine Ratio in a Large Cohort of Patients With CKDCharlotte Behning, Ulla T Schultheiss, Jennifer Nadal, et al.
Kidney Medicine|August 1, 2020
Inflammation and Erythropoiesis-Stimulating Agent Response in Hemodialysis Patients: A Self-matched Longitudinal Study of Anemia Management in the Dialysis Outcomes and Practice Patterns Study (DOPPS)Angelo Karaboyas, Hal Morgenstern, Nancy L Fleischer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 28, 2019
Comparability of Plasma Iohexol Clearance Across Population-Based CohortsBjørn O Eriksen, Elke Schaeffner, Toralf Melsom, et al.
Journal of the American Society of Nephrology : JASN|December 31, 2005
Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease studyEva Boes, Danilo Fliser, Eberhard Ritz, et al.
Cardiovascular Research|February 16, 2012
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular diseaseAndreas Tomaschitz, Eberhard Ritz, Burkert Pieske, et al.
Circulation|August 25, 2010
Homoarginine, cardiovascular risk, and mortalityWinfried März, Andreas Meinitzer, Christiane Drechsler, et al.
Kidney International|March 23, 2012
Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockersHiddo J Lambers Heerspink, Frank A Holtkamp, Hans-Henrik Parving, et al.
Pageof 36